8-K
Current Report
Cadrenal Therapeutics, Inc. Filed Acc 0001213900-26-038014
Material agreement · Unregistered share sale · Shareholder rights changed
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
- Item 3.03 Material modification to rights of security holders
From the SEC's structured data for this filing
Loading ea0284507-8k_cadrenal.htm…